Abnova (Taiwan) Corporation (TPE:4133)
Taiwan · Delayed Price · Currency is TWD 20.80
+0.05 (0.24%)
Aug 26, 2026, 1:30 PM CST
Abnova (Taiwan) Market Cap
Abnova (Taiwan) has a market cap or net worth of 1.26 billion as of August 25, 2026. Its market cap has decreased by -18.63% in one year.
Market Cap
1.26B
Enterprise Value
868.55M
Revenue
345.45M
Ranking
n/a
PE Ratio
27.85
Stock Price
20.80
ChartMarket Cap Chart
Since May 27, 2008, Abnova (Taiwan)'s market cap has decreased from 2.91B to 1.26B, a decrease of -56.81%. That is a compound annual growth rate of -4.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 1.26B | -8.59% |
| Dec 31, 2025 | 1.37B | -23.44% |
| Dec 31, 2024 | 1.80B | -15.53% |
| Dec 29, 2023 | 2.13B | -14.81% |
| Dec 30, 2022 | 2.49B | -5.40% |
| Dec 30, 2021 | 2.64B | -25.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Greenyn Biotechnology | 1.55B |
| Advagene Biopharma | 1.51B |
| Andros Pharmaceuticals Co.,Ltd | 1.51B |
| GenMont Biotech Incorporation | 1.37B |
| NeoCore Technology | 1.26B |
| Enimmune | 1.19B |
| U-Neuron Biomedical | 1.16B |
| LabTurbo Biotech | 1.14B |